Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$13.94 - $24.12 $697,000 - $1.21 Million
-50,000 Closed
0 $0
Q3 2019

Oct 29, 2019

BUY
$13.89 - $23.16 $694,500 - $1.16 Million
50,000 New
50,000 $758,000
Q1 2019

May 15, 2019

SELL
$12.61 - $22.33 $252,200 - $446,599
-20,000 Closed
0 $0
Q4 2018

May 15, 2019

BUY
$12.41 - $22.98 $248,200 - $459,600
20,000 New
20,000 $272,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Requisite Capital Management, LLC Portfolio

Follow Requisite Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Requisite Capital Management, LLC with notifications on news.